Every 10-Q that Chemed Corporation (CHE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CHE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHE filings page.
Chemed Corporation reported second quarter 2026 service revenues and sales of 673,251 thousand, up from 618,798 thousand a year earlier. Net income was 67,703 thousand versus 52,493 thousand, with diluted EPS of $5.13 compared with $3.57. For the first six months, service revenues and sales were 1,330,764 thousand and net income 134,005 thousand, producing diluted EPS of $9.97 versus $8.43.
The VITAS hospice segment generated second quarter service revenues and sales of 443,341 thousand, while Roto-Rooter contributed 229,910 thousand. Segment income from operations was 73,709 thousand for VITAS and 37,232 thousand for Roto-Rooter, offset by a 21,737 thousand corporate loss. Effective tax rates were 25.9% for the quarter and 25.6% year-to-date, close to prior-year levels.
Operating cash flow for the first half of 2026 was 173,032 thousand. Investing cash outflows of 66,027 thousand included 33,540 thousand for business combinations and 32,639 thousand of capital expenditures. Financing activities used 141,298 thousand, largely from 287,521 thousand of share repurchases and 16,049 thousand of dividends, alongside 140,000 thousand of long-term debt, leaving cash at 40,222 thousand.
Chemed Corporation reported first-quarter 2026 service revenues and sales of $657.5 million, up modestly from $646.9 million a year earlier. Net income was $66.3 million versus $71.8 million, as higher costs and expenses offset revenue growth.
Hospice segment VITAS generated net revenue of $420.0 million, driven by a 2.2% increase in days of care and Medicare rate increases. Roto-Rooter revenue was $237.5 million, slightly below last year, with softer water restoration and contractor activity despite higher pricing in core plumbing and drain services.
The company produced net cash from operating activities of $88.2 million, used $190.0 million to repurchase 500,000 shares, and ended the quarter with $91.2 million of long-term debt under its revolving credit facility and $16.9 million of cash and cash equivalents.
Chemed (CHE) reported Q3 2025 results. Service revenues and sales were $624.9 million, up from $606.2 million a year ago. Net income was $64.2 million versus $75.8 million, and diluted EPS was $4.46 compared with $5.00. Segment revenue was $407.7 million at VITAS and $217.2 million at Roto‑Rooter.
For the first nine months, revenue reached $1.89 billion (vs. $1.79 billion) with net income of $188.5 million (vs. $211.7 million). Cash from operations was $254.7 million, supporting $253.5 million of share repurchases year‑to‑date, including $180.8 million in Q3. Cash was $129.8 million, and approximately $404.5 million remained available under the revolving credit facility. The company paid a $0.60 per share dividend in Q3; shares outstanding were 14,164,195 as of September 30, 2025. In VITAS, an Administrative Law Judge largely upheld higher‑level‑of‑care billings; the Medicare Administrative Contractor refunded the previously deposited amount, reducing the overpayment to a de minimis figure. Board repurchase authorization remaining was $301.8 million.